Health__B-ORG Policy__I-ORG Changes:__I-ORG In__I-ORG November__I-ORG 2009,__I-ORG Walsh__I-ORG and__I-ORG Toleman__I-ORG were__O part__O of__O a__O UK-wide__B-ORG Department__I-ORG of__I-ORG Health__I-ORG (DoH)__I-ORG call__O alerting__O all__O UK__B-LOC hospitals__O and__O departments__O (through__O the__O Public__B-ORG Health__I-ORG England__I-ORG Reference__I-ORG Laboratory)__I-ORG to__O this__O new__O type__O of__O antibiotic__O resistance.5.1__O Their__O NDM-1__O studies__O were__O used__O to__O invoke__O mandatory__O screening__O be__O conducted__O for__O all__O patients__O arriving__O from__O overseas__O hospitals__O -__O these__O proposals__O were__O fully__O adopted__O by__O the__O UK__B-ORG DoH.__I-ORG
5.1__O The__O ECDC__B-ORG called__O for__O greater__O surveillance__O and__O enhanced__O European-wide__B-MISC infection__O control__O measures__O to__O contain__O the__O threat__O of__O NDM-1__B-MISC -__O see__O Table__B-ORG 2__O of__O reference__O 5.2.__O
In__O South__B-ORG Africa,__I-ORG the__O National__B-ORG Institute__I-ORG for__I-ORG Communicable__I-ORG Diseases__I-ORG issued__O a__O nationwide__O alert__O calling__O for__O increased__O infection__O control__O measures__O due__O to__O NDM-1.__B-LOC
5.3__O In__O Canada__B-LOC (through__O governmental__O agency__O focusing__O on__O practice__O and__O policy__O interventions__O for__O Canadian__B-MISC populations),__O alerts__O and__O altered__O policies__O have__O been__O implemented.__O
5.4__O In__O August__O 2010__O as__O a__O direct__O response__O to__O the__O first__O publication,__O the__O Ministry__B-ORG of__I-ORG Health__I-ORG and__I-ORG Family__I-ORG Welfare__I-ORG together__O with__O the__O National__B-ORG Centre__I-ORG for__I-ORG Disease__I-ORG Control__I-ORG in__I-ORG India__I-ORG constituted__O a__O National__B-ORG Task__I-ORG Force__I-ORG for__O the__O containment__O of__O Antimicrobial__O resistance.__O
In__O March__O 2011,__O this__O task__O force__O produced__O India's__B-ORG first__O ever__O national__O antibiotic__O policy__O document__O entitled__O "National__B-ORG Policy__I-ORG for__I-ORG Containment__I-ORG of__I-ORG Antimicrobial__I-ORG Resistance__I-ORG in__O India"__B-LOC (http://nicd.nic.in/ab_policy.pdf).__O
In__O August__O 2012,__O all__O major__O Indian__B-MISC clinical,__O academic__O and__O research__O bodies__O met__O in__O Chennai__B-LOC to__O discuss__O for__O the__O first__O time__O implementing__O 1.__O
Antibiotic__O stewardship.__O
2.__O
Infection__B-PER control__O and__O 3.__O
National__B-ORG Surveillance.__I-ORG
This__O document,__O entitled__O "The__B-ORG Chennai__I-ORG Declaration__I-ORG -__O A__O Roadmap__B-PER to__O tackle__O the__O Challenge__B-ORG of__I-ORG Antimicrobial__I-ORG Resistance",__I-ORG is__O a__O direct__O response__O to__O studies__O in__O India,__O led__O by__O Walsh__B-PER and__O Toleman__B-PER that__O have__O persuaded__O the__O Indian__B-MISC government__O to__O acknowledge__O the__O very__O serious__O antibiotic__O resistance__O issues.5.5__O Walsh__B-PER is__O advising__O the__O authors__O of__O the__O Chennai__B-LOC declaration__O and__O the__O Pakistani__B-MISC health__O authorities__O on__O antibiotic__O stewardship__O and__O infection__O control__O issues.__O
IMPACT:__O Prevention__O of__O the__O spread__O of__O NDM-1__O bacteria__O throughout__O UK__B-LOC hospital__O wards__O as__O witnessed__O by__O the__O recent__O example__O published__O in__O the__O Lancet__B-ORG and__O International__O policy__O changes__O e.g.__O
India.5.1-5.5__O Public__O Behaviour__O Changes:__O These__O studies__O encouraged__O the__O Indian__B-MISC government__O to__O take__O antibiotic__O resistance__O more__O seriously.__O
The__O work__O was__O the__O catalyst__O for__O the__O Indian__B-MISC government__O to__O organise__O emergency__O meetings__O resulting__O in__O the__O publication__O of__O the__O first__O Indian__B-MISC Government__I-MISC policies__O on__O tackling__O antibiotic__O resistance.__O
The__O subsequent__O Chennai__B-PER agreement__O has__O time__O lined__O a__O road__O map__O for__O implementation__O of__O antibiotic__O stewardship__O and__O infection__O control__O programs__O in__O response__O to__O Walsh's__O description__O of__O the__O issues__O of__O multi-drug__O resistance__O in__O India__B-LOC -__O these__O are__O currently__O being__O implemented__O across__O all__O of__O India__B-LOC so__O their__O impact__O is__O yet__O to__O be__O assessed.5.5__O A__O secondary__O behaviour__O change__O has__O resulted__O from__O the__O work__O because__O it__O highlights__O the__O threat__O posed__O by__O the__O growing__O industry__O of__O medical__O tourism__O and__O international__O cosmetic__O surgery;__O this__O has__O caused__O clashes__O with__O Indian__B-MISC private__O hospitals__O undertaking__O cosmetic__O surgery.__O
IMPACT:__O As__O a__O direct__O result__O of__O the__O research,__O stricter__O control__O of__O antibiotic__O stewardship__O and__O national__O infection__O control__O programs__O are__O being__O implemented__O in__O India.__B-LOC
The__O research__O highlighted__O some__O of__O the__O medical__O issues,__O i.e.__O
post-surgical__O infections,__O associated__O with__O medical__O tourism.__O
Public__O Awareness__O of__O a__O Health__O Risk:__O Immediately__O following__O publication__O of__O the__O seminal__O paper__O in__O Lancet__B-ORG Infectious__I-ORG Diseases,__I-ORG NDM-1__I-ORG was__O the__O fourth__O biggest__O story__O world-wide,__O the__O lead__O story__O on__O the__O BBC__B-ORG 6__I-ORG o'clock__O news__O 5.6__O and__O broadcasted__O by__O ABC,__B-ORG CNN,__I-ORG Al-Jazeera,__I-ORG China-TV,__I-ORG India__I-ORG Today,__I-ORG SKY,__I-ORG ITV,__I-ORG Channel__I-ORG 4__O and__O Channel__B-LOC 5.__O
On__O 11th__O August,__O 2010__O the__O NDM-1__B-ORG story__O was__O covered__O on__O the__O front__O pages__O of__O the__O Telegraph,__B-ORG Independent,__I-ORG Guardian,__I-ORG Mail,__I-ORG Times,__I-ORG Financial__I-ORG Times,__I-ORG Sun__I-ORG and__O Mirror.5.6-5.8__O Interviews__O with__O the__O Telegraph,__B-ORG Times,__I-ORG Guardian__I-ORG and__O Independent__B-MISC provided__O informed__O editorials__O in__O the__O weekend__O editions5.6-5.8__O On__O the__O web,__O the__O NDM-1__O feature__O registered__O 4.7__O million__O internet__O hits__O in__O 2__O days__O (11th-12th__O August).__B-ORG
Moreover,__O the__O follow-up__O study__O published__O in__O April__O 2011__O was__O covered__O widely__O in__O India__B-LOC and__O internationally__O including__O by__O the__O BBC__B-ORG -__O this__O was__O the__O first__O study__O linking__O the__O emergence__O of__O "superbugs"__O to__O the__O lack__O of__O sanitation__O in__O developing__O countries.__O
This__O study__O was__O covered__O at__O the__O time__O by__O a__O Channel__B-ORG 4__O documentary__O and__O more__O recently__O by__O BBC__B-ORG Horizon__I-ORG and__O ABC__B-ORG public__O awareness__O programs.5.9,__O 5.10__O IMPACT:__B-ORG This__O global__O coverage__O changed__O the__O public's__O perception__O of__O "superbugs"__B-ORG and__O demonstrated__O that__O resistance__O can__O be__O readily__O spread__O from__O one__O bacterium__O to__O another__O -__O a__O clear__O demarcation__O from__O MRSA__B-LOC and__O "C.__B-LOC difficile".__O
This__O perception__O resulted__O in__O international__O alerts__O by__O the__O Communicable__B-LOC Disease__I-LOC Centre__I-LOC (CDC)__O (USA),__O European__B-MISC CDC__O (ECDC)__B-ORG World__I-ORG Health__I-ORG Organisation__I-ORG (WHO)__I-ORG etc.__O
and__O resulted__O in__O global__O behavioural__O and__O policy__O changes.__O
The__O Control__B-ORG of__I-ORG Diseases__I-ORG has__O Changed.__O
The__O follow__O up__O study__O describing__O the__O discovery__O of__O NDM-1__O in__O the__O Indian__B-MISC tap-water__O and__O environment__O has__O directly__O led__O to__O the__O Indian__B-MISC government__O issuing__O chlorine__O tablets__O to__O sanitise__O tap__O water__O for__O New__B-LOC Delhi__I-LOC residents__O unable__O to__O afford__O bottled__O water.3.6__O This__O practice__O continues,__O although__O control__O studies__O have__O not__O been__O undertaken__O in__O India__B-LOC to__O assess__O the__O impact__O of__O the__O intervention.__O
IMPACT:__O Introduction__O of__O potable__O water__O treatment__O in__O New__B-LOC Delhi.__I-LOC
Impact__O on__O National__B-ORG and__I-ORG International__B-MISC Organisations:__I-MISC The__I-MISC impact__I-MISC of__I-MISC NDM-1__I-MISC has__O been__O detailed__O by__O many__O international__O health__O organisations__O including:__O Individual__B-ORG national__O governments__O (China,__B-PER Korea,__I-PER France,__B-PER USA__I-PER and__O UK)__B-ORG 5.1-5.5,__O the__O European__B-ORG Society__I-ORG of__I-ORG Clinical__I-ORG Microbiology__I-ORG and__O Infectious__O Diseases,__O (CDC)__O (USA),__O WHO,__O European__B-ORG Parliament,__I-ORG and__O World__B-ORG Health__I-ORG Assembly.__I-ORG
As__O a__O result__O of__O this__O international__O interest,__O Walsh__B-PER has__O been__O invited__O to__O give__O over__O 46__O international__O talks__O (including__O Australia,__B-PER Norway,__I-PER China,__I-PER USA,__O Canada,__B-PER Saudi__I-PER Arabia,__I-PER Thailand,__I-PER Vietnam,__I-PER Japan,__I-PER Pakistan__B-LOC and__O India)__B-LOC and__O Toleman__B-LOC has__O given__O talks__O in__O Italy,__B-LOC Switzerland,__I-LOC Austria,__I-LOC USA,__I-LOC Saudi__I-LOC Arabia,__I-LOC and__O the__O UK.__B-LOC
Walsh__B-PER has__O addressed__O the__O European__B-MISC parliament__O with__O the__O director__O of__O the__O WHO,__B-ORG Margaret__I-ORG Chan__I-ORG (http://www.who.int/dg/speeches/2012/amr_20120314/en/__O available__O on__O request__O from__O HEI)__B-LOC on__O NDM-1;__B-ORG Toleman__I-ORG has__O addressed__O NATO__B-ORG surgeons__O at__O the__O NATO__B-ORG headquarters__O in__O Brussels.__B-LOC
Walsh__B-PER has__O recently__O been__O asked__O by__O the__O WHO__B-ORG and__O the__O Chinese__B-MISC CDC__O to__O act__O as__O a__O consultant__O on__O international__O antibiotic__O resistance__O surveillance__O and__O was__O asked__O to__O become__O a__O member__O on__O the__O World__B-ORG Health__I-ORG Associated__I-ORG infections__O forum__O (http://www.hai-forum.com/__O webcast).__O
Walsh__B-PER has__O also__O been__O asked__O by__O the__O UK__B-LOC government__O "GoScience"__O to__O write__O a__O positioning__O paper__O predicting__O resistance__O rates__O in__O 2030__O and__O its__O impact__O on__O human__O health.__O
.__O
IMPACT:__O Mission__B-MISC statements__O and__O general__O alerts__O on__O the__O impact__O of__O NDM-1__B-ORG issued__O by__O the__O above__O organisations__O including__O national__O screening__O programs.__O
Outcomes__O for__O Patients__O have__O Improved:__O The__O research__O on__O NDM-1__O has__O altered__O treatment__O of__O individuals__O presenting__O with__O NDM-1__B-ORG positive__O infections.__O
The__O work__O documenting__O NDM-1__O resistance__O profiles__O and__O prevention__O measures__O for__O spread__O is__O known__O throughout__O the__O UK.5.1__B-MISC A__I-MISC recent__O case__O was__O of__O a__O traveller__O from__O India__B-LOC who__O required__O emergency__O admission__O in__O at__O Southmead__B-LOC Hospital,__I-LOC Bristol.__I-LOC
Treatment__O as__O above__O prevented__O further__O spread__O of__O NDM-1__B-ORG pathogens.3.6__O IMPACT:__O Production__O of__O guidelines,__O in__O collaboration__O with__O the__O HPA,__B-MISC for__O patient__O treatment__O and__O management.__O
Less__O harm__O to__O patients,__O limited__O spread__O of__O "superbugs"__O in__O UK__B-LOC hospitals__O and__O reduced__O costs.3.6__O
